Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (17): 2709-2715.doi: 10.3969/j.issn.2095-4344.1723

Previous Articles     Next Articles

Lentiviral-mediated transplantation of olfactory ensheathing cells modified by ciliary neurotrophic factor for treatment of spinal cord injury

Ma Jiehua1, Zhang Dan2, Huo Yanli1, Wei Yawei1, Sun Lin1, Zhao Yu1   

  1. 1Department of Anatomy, Hebei North University, Zhangjiakou 075000, Hebei Province, China; 2Department of Stomatology, the First Hospital of Zhangjiakou, Zhangjiakou 075000, Hebei Province, China
  • Revised:2019-01-22 Online:2019-06-18 Published:2019-06-18
  • Contact: Zhao Yu, MD, Associate professor, Department of Anatomy, Hebei North University, Zhangjiakou 075000, Hebei Province, China
  • About author:Ma Jiehua, Master, Lecturer, Department of Anatomy, Hebei North University, Zhangjiakou 075000, Hebei Province, China
  • Supported by:

    the Medical Research Project of Hebei Provincial Health and Family Planning Commission, No. 20180809 (to MJH); and the Key Project of Hebei Provincial Department of Education, No. ZD2016094 (to ZY)

Abstract:

BACKGROUND: Previous studies have confirmed that both ciliary neurotrophic factor and olfactory ensheathing cells have a certain therapeutic effect on spinal cord injury, but there is no report on whether their combination treatment has a better therapeutic effect.
OBJECTIVE: To explore the effect of lentiviral-mediated transplantation of olfactory ensheathing cells modified with ciliary neurotrophic factor gene in rats with spinal cord injury and its related mechanisms. 
METHODS: (1) In vitro experiment: There were four groups in the in vitro experiment: spinal cord neurons in control group and model group were cultured alone, while in overexpression co-culture group and normal co-culture group, Transwell chamber was used to establish the co-culture model of spinal cord neurons and olfactory ensheathing cells modified by ciliary neurotrophic factor gene or not. Alginate was given to damage the cells in the latter three groups. After 12 hours of co-culture, cell counting kit-8 assay was used to detect cell viability; qRT-PCR and western blot were used to detect the expression of BAX, BCL-2, Caspase 3 and ciliary neurotrophic factor in spinal neurons. (2) In vivo experiment: There were four groups in the in vivo experiment: sham operation group, model group, treatment group, and combination treatment group. Modified Allen’s method was used to make the rat model of spinal cord injury in the latter three groups. At 1 week after modeling, 5 µL of olfactory ensheathing cell suspension or ciliary neurotrophic factor overexpressing olfactory ensheathing cell suspension was injected 1 mm above and below the injured site in the treatment and combination treatment groups, respectively; similarly, the same volume of culture medium was given in the sham operation and model groups. At 4 weeks after treatment, Basso, Beattie and Bresnahan score and grid-climbing test were conducted to evaluate the motor ability of rats; hematoxylin-eosin staining was used to detect the pathological progression of spinal cord injury; and qRT-PCR and western blot were used to detect the expression of BAX, BCL-2, Caspase 3 and ciliary neurotrophic factor in spinal cord tissues. 
RESULTS AND CONCLUSION: Olfactory ensheathing cells modified with ciliary neurotrophic factor gene could significantly alleviate cell injury and spinal cord injury (P < 0.001), increase the expression of ciliary neurotrophic factor (P < 0.01) and decrease the expression of apoptosis-related molecules BAX, BCL-2 and Caspase 3 (P < 0.01). To conclude, transplantation of olfactory ensheathing cells modified by ciliary ganglion neurotrophic factor gene can improve the motor function after spinal cord injury, which may be related to the down-regulation of BAX, BCL-2 and Caspase-3 expression and reduction in the apoptosis of spinal cord neurons.

Key words: spinal cord injury, olfactory ensheathing cells, spinal cord neurons, ciliary neurotrophic factor, neuronal apoptosis

CLC Number: